Restasis

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 23 USDMF, 11 CEP/COS, 9 JDMF, 1 EU WC, 12 KDMF, 21 NDC API, 1 VMF, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

33 Drugs in Development

33 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

308 FDF Dossiers, 53 FDA Orange Book, 159 Europe, 23 Canada, 48 Australia, 7 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 100MG, CAPSULE;ORAL - 25MG, CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 Rochem International Inc, 2 SPI Pharma, 3 Seqens, 9 DKSH, 1 Jai Radhe Sales, 1 PMC Isochem, 2 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 19 BASF, 1 Bioplus Life Sciences, 1 Clariant, 3 Corel Pharma Chem, 2 Finar, 7 Gangwal Chemicals, 2 Kerry, 3 Lonza Capsugel, 1 Lubrizol Life Science Health, 1 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Pluviaendo, 1 Qualicaps, 11 Roquette, 10 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

31 Solubilizers, 28 Topical, 20 Parenteral, 18 Film Formers & Plasticizers, 16 Thickeners and Stabilizers, 15 Emulsifying Agents, 14 Coating Systems & Additives, 10 Surfactant & Foaming Agents, 9 Fillers, Diluents & Binders, 9 Controlled & Modified Release, 8 Empty Capsules, 7 Taste Masking, 6 Granulation, 5 Direct Compression, 4 API Stability Enhancers, 4 Lubricants & Glidants, 4 Co-Processed Excipients, 3 Coloring Agents, 2 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin, 1 Disintegrants & Superdisintegrants

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 161 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 50 Finished Drug Prices, 13 Annual Reports

MARKET PLACE

26 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

27 US Patents, 3 US Exclusivities, 60 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 1 JP, 3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

FILTER :

filter Product Reset all filters

13 All

01 1Neoral

02 1Neoral/Sandimmun

03 1Neoral/Sandimmun(E)

04 2Neoral/Sandimmun(e)

05 8Restasis

List of Suppliers

Reset Filter

Restasis

Restasis

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers

23 USDMF

11 CEP/COS

9 JDMF

1 EU WC

12 KDMF

21 NDC API

1 VMF

13 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

33 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

308 FDF Dossiers

53 FDA Orange Book

159 Europe

23 Canada

48 Australia

7 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 100MG

CAPSULE;ORAL - 25MG

CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Evonik

1 Rochem International Inc

2 SPI Pharma

3 Seqens

9 DKSH

1 Jai Radhe Sales

1 PMC Isochem

2 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

4 ACG Worldwide

7 Actylis

1 Aeon Procare

19 BASF

1 Bioplus Life Sciences

1 Clariant

3 Corel Pharma Chem

2 Finar

7 Gangwal Chemicals

2 Kerry

3 Lonza Capsugel

1 Lubrizol Life Science Health

1 Microlex e.U

3 Nanjing Bold Chemical

2 Nomisma Healthcare

2 Pluviaendo

1 Qualicaps

11 Roquette

10 Seppic

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

2 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

31 Solubilizers

28 Topical

20 Parenteral

18 Film Formers & Plasticizers

16 Thickeners and Stabilizers

15 Emulsifying Agents

14 Coating Systems & Additives

10 Surfactant & Foaming Agents

9 Fillers, Diluents & Binders

9 Controlled & Modified Release

8 Empty Capsules

7 Taste Masking

6 Granulation

CAPSULE;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons